TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: HIV Risk Reduction and Drug Abuse Treatment in Malaysia
Brief Summary: A randomized clinical trial comparing drug abuse and HIV risk reduction counseling (DC-HIV) alone, DC-HIV combined with naltrexone maintenance, and DC-HIV combined with buprenorphine maintenance for the treatment of heroin addicts in Malaysia.


Options:
A: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine
B: Intervention Type: DRUG; Name: Buprenorphine/Subutex; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Drug counseling; Assigned to Arm(s): N/A
C: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Probuphine | Arm Label: Group B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Probuphine; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Group B
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Clinic-based substance abuse treatment with buprenorphine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Case management and referred substance abuse treatment | Intervention Type: BEHAVIORAL; Name: Clinic-based substance abuse treatment with buprenorphine; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Case management and referred substance abuse treatment; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lifestyle Physical Activity for Fibromyalgia
Brief Summary: The purpose of this study is to determine the effect of 3 months of daily, 30-minute lifestyle physical activity on pain and fatigue in inactive adults with fibromyalgia (FM).


Options:
A: Arm Label: Tai Chi Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi Intervention | Arm Label: Control Intervention; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control Intervention | Intervention Type: BEHAVIORAL; Name: Tai Chi Intervention; Assigned to Arm(s): Tai Chi Intervention | Intervention Type: BEHAVIORAL; Name: Control Intervention; Assigned to Arm(s): Control Intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle physical activity (LPA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fibromyalgia education | Intervention Type: BEHAVIORAL; Name: Lifestyle physical activity (LPA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Fibromyalgia education; Assigned to Arm(s): 2
C: Intervention Type: BEHAVIORAL; Name: walking program, resistance muscular exercise; Assigned to Arm(s): N/A
D: Arm Label: Strength training; Type: EXPERIMENTAL; Interventions: Behavioral: Strength training | Arm Label: Aerobic exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Aerobic exercise | Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): Strength training | Intervention Type: BEHAVIORAL; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lifestyle Physical Activity for Fibromyalgia
Brief Summary: The purpose of this study is to determine the effect of 3 months of daily, 30-minute lifestyle physical activity on pain and fatigue in inactive adults with fibromyalgia (FM).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle physical activity (LPA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fibromyalgia education | Intervention Type: BEHAVIORAL; Name: Lifestyle physical activity (LPA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Fibromyalgia education; Assigned to Arm(s): 2
B: Arm Label: Dance Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dance | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: Other: Control Group | Intervention Type: BEHAVIORAL; Name: Dance; Assigned to Arm(s): Dance Group | Intervention Type: OTHER; Name: Control Group; Assigned to Arm(s): Control Group
C: Arm Label: A. High intensive exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise | Arm Label: B. Low-intensive exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active comparator: low intensive exercise | Intervention Type: BEHAVIORAL; Name: Physical exercise; Assigned to Arm(s): A. High intensive exercise | Intervention Type: BEHAVIORAL; Name: Active comparator: low intensive exercise; Assigned to Arm(s): B. Low-intensive exercise
D: Intervention Type: BEHAVIORAL; Name: self-management program; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lifestyle Physical Activity for Fibromyalgia
Brief Summary: The purpose of this study is to determine the effect of 3 months of daily, 30-minute lifestyle physical activity on pain and fatigue in inactive adults with fibromyalgia (FM).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle physical activity (LPA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fibromyalgia education | Intervention Type: BEHAVIORAL; Name: Lifestyle physical activity (LPA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Fibromyalgia education; Assigned to Arm(s): 2
B: Arm Label: water-based exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: water-based exercise | Arm Label: land-based exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: land-based exercise intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: water-based exercise; Assigned to Arm(s): water-based exercise intervention | Intervention Type: BEHAVIORAL; Name: land-based exercise intervention; Assigned to Arm(s): land-based exercise intervention
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Attention Control Counseling | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Attention Control Counseling; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): 2
D: Arm Label: Tai Chi; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lower frequency, shorter period of Tai Chi, Behavioral: Higher frequency, shorter period of Tai Chi, Behavioral: Shorter frequency, longer period of Tai Chi, Behavioral: Higher frequency, longer period of Tai Chi | Arm Label: Aerobic Exercise Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Aerobic Exercise Training | Intervention Type: BEHAVIORAL; Name: Lower frequency, shorter period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Higher frequency, shorter period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Shorter frequency, longer period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Higher frequency, longer period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Aerobic Exercise Training; Assigned to Arm(s): Aerobic Exercise Training

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lifestyle Physical Activity for Fibromyalgia
Brief Summary: The purpose of this study is to determine the effect of 3 months of daily, 30-minute lifestyle physical activity on pain and fatigue in inactive adults with fibromyalgia (FM).


Options:
A: Arm Label: Tai Chi Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi Intervention | Arm Label: Control Intervention; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control Intervention | Intervention Type: BEHAVIORAL; Name: Tai Chi Intervention; Assigned to Arm(s): Tai Chi Intervention | Intervention Type: BEHAVIORAL; Name: Control Intervention; Assigned to Arm(s): Control Intervention
B: Intervention Type: BEHAVIORAL; Name: walking program, resistance muscular exercise; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle physical activity (LPA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fibromyalgia education | Intervention Type: BEHAVIORAL; Name: Lifestyle physical activity (LPA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Fibromyalgia education; Assigned to Arm(s): 2
D: Arm Label: A. High intensive exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise | Arm Label: B. Low-intensive exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active comparator: low intensive exercise | Intervention Type: BEHAVIORAL; Name: Physical exercise; Assigned to Arm(s): A. High intensive exercise | Intervention Type: BEHAVIORAL; Name: Active comparator: low intensive exercise; Assigned to Arm(s): B. Low-intensive exercise

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lifestyle Physical Activity for Fibromyalgia
Brief Summary: The purpose of this study is to determine the effect of 3 months of daily, 30-minute lifestyle physical activity on pain and fatigue in inactive adults with fibromyalgia (FM).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle physical activity (LPA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fibromyalgia education | Intervention Type: BEHAVIORAL; Name: Lifestyle physical activity (LPA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Fibromyalgia education; Assigned to Arm(s): 2
B: Arm Label: Tai Chi; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lower frequency, shorter period of Tai Chi, Behavioral: Higher frequency, shorter period of Tai Chi, Behavioral: Shorter frequency, longer period of Tai Chi, Behavioral: Higher frequency, longer period of Tai Chi | Arm Label: Aerobic Exercise Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Aerobic Exercise Training | Intervention Type: BEHAVIORAL; Name: Lower frequency, shorter period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Higher frequency, shorter period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Shorter frequency, longer period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Higher frequency, longer period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Aerobic Exercise Training; Assigned to Arm(s): Aerobic Exercise Training
C: Arm Label: Tai Chi Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi Intervention | Arm Label: Control Intervention; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control Intervention | Intervention Type: BEHAVIORAL; Name: Tai Chi Intervention; Assigned to Arm(s): Tai Chi Intervention | Intervention Type: BEHAVIORAL; Name: Control Intervention; Assigned to Arm(s): Control Intervention
D: Intervention Type: BEHAVIORAL; Name: self-management program; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lifestyle Physical Activity for Fibromyalgia
Brief Summary: The purpose of this study is to determine the effect of 3 months of daily, 30-minute lifestyle physical activity on pain and fatigue in inactive adults with fibromyalgia (FM).


Options:
A: Arm Label: Workshop; Type: EXPERIMENTAL; Interventions: Behavioral: Affective Self-Awareness workshop | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Affective Self-Awareness workshop; Assigned to Arm(s): Workshop
B: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Attention Control Counseling | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Attention Control Counseling; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): 2
C: Arm Label: Group education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group education | Arm Label: 8-form Yang-style Tai chi program; Type: EXPERIMENTAL; Interventions: Behavioral: 8-form Yang-style Tai chi | Intervention Type: BEHAVIORAL; Name: 8-form Yang-style Tai chi; Assigned to Arm(s): 8-form Yang-style Tai chi program | Intervention Type: BEHAVIORAL; Name: Group education; Assigned to Arm(s): Group education
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle physical activity (LPA) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fibromyalgia education | Intervention Type: BEHAVIORAL; Name: Lifestyle physical activity (LPA); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Fibromyalgia education; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Computerized EMR-Assisted Smoking Cessation (CEASCE)
Brief Summary: RATIONALE: Computer-based stop smoking programs may assist doctors in helping patients stop smoking.

PURPOSE: This randomized clinical trial is studying how well a computer-based stop smoking program works in assisting doctors in helping adults stop smoking.


Options:
A: Arm Label: Prevention Care Management; Type: EXPERIMENTAL; Interventions: Behavioral: Prevention Care Management | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Prevention Care Management; Assigned to Arm(s): Prevention Care Management
B: Arm Label: Targeted Feedback Reports; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Targeted Feedback Reports | Arm Label: Targeted Feedback Report; Type: EXPERIMENTAL; Interventions: Behavioral: Targeted Feedback Report | Intervention Type: BEHAVIORAL; Name: Targeted Feedback Reports; Assigned to Arm(s): Targeted Feedback Reports | Intervention Type: BEHAVIORAL; Name: Targeted Feedback Report; Assigned to Arm(s): Targeted Feedback Report
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: point of care patient report cards, Behavioral: Provider performance report card | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: point of care patient report cards | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Provider performance report card | Arm Label: 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: point of care patient report cards; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Provider performance report card; Assigned to Arm(s): 1, 3
D: Intervention Type: BEHAVIORAL; Name: smoking cessation intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: counseling intervention; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Computerized EMR-Assisted Smoking Cessation (CEASCE)
Brief Summary: RATIONALE: Computer-based stop smoking programs may assist doctors in helping patients stop smoking.

PURPOSE: This randomized clinical trial is studying how well a computer-based stop smoking program works in assisting doctors in helping adults stop smoking.


Options:
A: Intervention Type: PROCEDURE; Name: Computer-Assisted diagnostic Decision Support; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: written diagnostic guidelines; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: electronic therapeutic reminders; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Computer-Assisted Decision Support | Intervention Type: PROCEDURE; Name: Computer-Assisted Decision Support; Assigned to Arm(s): 2
C: Intervention Type: BEHAVIORAL; Name: smoking cessation intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: counseling intervention; Assigned to Arm(s): N/A
D: Arm Label: Electronic Decision Support; Type: EXPERIMENTAL; Interventions: Behavioral: Decision Support for ARI Management | Arm Label: Paper Decision Support; Type: EXPERIMENTAL; Interventions: Behavioral: Decision Support for ARI Management | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Decision Support for ARI Management; Assigned to Arm(s): Electronic Decision Support, Paper Decision Support

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Vitamins in HIV Progression and Transmission (A Trial of Vitamins and HAART in HIV Disease Progression)
Brief Summary: This study is a double-blind randomized clinical trial, conducted to examine the effects of multivitamins (including B, C, and E) on HIV disease progression among HIV-positive Tanzanian adult men and women taking highly active anti-retroviral therapy (HAART).


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Vitamin D 4000 IU; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): Vitamin D 4000 IU | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Multiple RDA multivitamins; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Multivitamins (including B, C and E) | Arm Label: Single RDA Multivitamins; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Multivitamins B, C and E | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins (including B, C and E); Assigned to Arm(s): Multiple RDA multivitamins | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins B, C and E; Assigned to Arm(s): Single RDA Multivitamins
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multivitamins | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins; Assigned to Arm(s): Multivitamins | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: A: tenofovir/vitamin D; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D supplement | Arm Label: B: tenofovir/placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: C: no tenofovir/vitamin D; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D supplement | Arm Label: D: no tenofovir/placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D supplement; Assigned to Arm(s): A: tenofovir/vitamin D, C: no tenofovir/vitamin D | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): B: tenofovir/placebo, D: no tenofovir/placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Placebo-Controlled, Double-Blind Cross-Over Trial of Opioids Versus Mexiletine in the Treatment of Postamputation Pain
Brief Summary: Persistent pain occurs in 50-85 percent of patients who experience the amputation of an extremity. This study will compare the effectiveness of morphine and mexiletine to placebo in the treatment of postamputation pain.

It is hypothesized that the effects of opioids and mexiletine on behavior and mental functioning in patients with postamputation pain are unlikely to be significant barriers to the clinical use of the drugs.


Options:
A: Arm Label: Injection with Saline; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Infiltration with Saline | Arm Label: Injection with Bupivacaine; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Infiltration with Bupivacaine | Intervention Type: PROCEDURE; Name: Infiltration with Saline; Assigned to Arm(s): Injection with Saline | Intervention Type: PROCEDURE; Name: Infiltration with Bupivacaine; Assigned to Arm(s): Injection with Bupivacaine
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vitamin Complex (placebo) | Arm Label: Pregabalin; Type: EXPERIMENTAL; Interventions: Drug: Pregabalin | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Pregabalin | Intervention Type: DRUG; Name: Vitamin Complex (placebo); Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: morphine and mexiletine; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: anti TNFa monoclonal antibody - Infliximab | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: anti TNFa monoclonal antibody - Infliximab; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Dexmedetomidine Used for Sedation During Elective Awake Fiberoptic Intubation
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of dexmedetomidine versus placebo used for sedation during elective awake fiberoptic intubation.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexmedetomidine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): 2
B: Arm Label: Dexmedetomidine; Type: EXPERIMENTAL; Interventions: Drug: Dexmedetomidine HCL Injection | Arm Label: Placebo (PBO); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dexmedetomidine HCL Injection; Assigned to Arm(s): Dexmedetomidine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo (PBO)
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Dexmedetomidine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): 2
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: NaCl 9/00 | Arm Label: dexmedetomidine; Type: EXPERIMENTAL; Interventions: Drug: dexmedetomidine | Intervention Type: DRUG; Name: NaCl 9/00; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: dexmedetomidine; Assigned to Arm(s): dexmedetomidine

Answer: B